Cipla’s US recovery, biosimilar pipeline key to future growth prospects
Cipla’s September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its strong India business and branded prescription therapies. Recent approvals for respiratory products and a growing biosimilar pipeline bolster Cipla’s optimism for future growth. Despite declining operating margins, the firm anticipates improvements supported by product […]
Tata Capital Q2 net profit rises 51% on higher income
Tata Capital’s second-quarter net profit rose 51% year-on-year to Rs 1,660 crore, supported by higher interest income and loan growth. Assets under management increased 26% to Rs 3.08 lakh crore, while floating-rate lending adjustments and margin improvement remain key priorities.
India’s growth momentum stays resilient despite global headwinds: RBI Deputy Governor Poonam Gupta
Reserve Bank Deputy Governor Poonam Gupta indicated that India’s real GDP growth fell short due to external shocks. She highlighted that India has managed over 7 percent growth despite challenging circumstances in recent years. Additionally, Gupta expressed confidence that improved global conditions could enhance growth by another percentage point. She discussed the importance of diversifying […]